Publisher Correction: Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency.
Where this comes from
- Record sourced from PubMed, PMID 30692700.
- Also identified by DOI 10.1038/s41591-019-0360-3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the version of this article originally published, there was an error in the legend for Extended Data Fig. 7. The legend for panel f was originally: "f, FACS analysis of IL7R<sup>-</sup>, CD62L<sup>-</sup> and CD45RA<sup>-</sup> expression on TRAC-1928ζ and TRAC-1XX CAR T cells at day 63 post CAR infusion (representative for at least n = 3 mice per group in one independent experiment)." The legend should have been: "f, FACS analysis of IL7R<sup>+</sup>, CD62L<sup>+</sup> and CD45RA<sup>+</sup> expression on TRAC-1928ζ and TRAC-1XX CAR T cells at day 63 post CAR infusion (representative for at least n = 3 mice per group in one independent experiment)." The error has been corrected in the HTML and PDF versions of this article.